PFG
IART icon

Piershale Financial Group’s Integra LifeSciences IART Stock Holding History

Piershale Financial Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-489
Closed -$13K – 149
2015
Q2 		$13K Buy
+489
New +$13K 0.01% 67

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Piershale Financial Group's IART Position: Q3 2015 in Review

Piershale Financial Group sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 489 shares — an estimated $13K sold.

Piershale Financial Group first reported a position in IART in Q2 2015 and held it in 1 quarter. The position peaked at $13K in Q2 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

  • Piershale Financial Group reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
  • Piershale Financial Group sold 489 Integra LifeSciences shares in Q3 2015, an estimated $13K.
  • Piershale Financial Group first reported a position in Integra LifeSciences in Q2 2015 and held it in 1 quarter.
  • Piershale Financial Group's Integra LifeSciences position peaked at $13K in Q2 2015.
  • 189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on Piershale Financial Group's 13F filing for Q3 2015, filed 27 Oct 2015.